Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)

CNY 16.08

(0.06%)

EBITDA Summary of Zhejiang Shengda Bio-Pharm Co., Ltd.

  • Zhejiang Shengda Bio-Pharm Co., Ltd.'s latest annual EBITDA in 2023 was 34.44 Million CNY , down -35.29% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was 11.26 Million CNY , down -68.99% from previous quarter.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported an annual EBITDA of 114.41 Million CNY in 2022, down -22.42% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported an annual EBITDA of 163.8 Million CNY in 2021, down -47.08% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported a quarterly EBITDA of 11.26 Million CNY for 2024 Q3, down -68.99% from previous quarter.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported a quarterly EBITDA of 20.95 Million CNY for 2024 Q2, up 42.88% from previous quarter.

Annual EBITDA Chart of Zhejiang Shengda Bio-Pharm Co., Ltd. (2023 - 2012)

Historical Annual EBITDA of Zhejiang Shengda Bio-Pharm Co., Ltd. (2023 - 2012)

Year EBITDA EBITDA Growth
2023 34.44 Million CNY -35.29%
2022 114.41 Million CNY -22.42%
2021 163.8 Million CNY -47.08%
2020 302.85 Million CNY 142.08%
2019 111.55 Million CNY 25.85%
2018 92.1 Million CNY -16.31%
2017 119.37 Million CNY 14.58%
2016 91.44 Million CNY -33.05%
2015 140.77 Million CNY 90.46%
2014 80.9 Million CNY 47.49%
2013 56.27 Million CNY -38.03%
2012 87.76 Million CNY 0.0%

Peer EBITDA Comparison of Zhejiang Shengda Bio-Pharm Co., Ltd.

Name EBITDA EBITDA Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 99.048%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 91.207%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 99.467%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 96.637%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 98.237%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 96.968%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 96.455%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 137.943%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 99.244%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 1037.33%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 99.313%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY 69.035%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 94.916%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 87.027%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 98.402%
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 87.478%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY 77.839%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 97.843%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 97.85%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 92.737%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY 83.574%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 92.808%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 95.323%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY 81.621%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 90.298%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 95.365%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 114.714%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 99.159%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 95.704%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY 81.528%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 97.73%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 98.448%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 87.079%
China National Medicines Corporation Ltd. 2.82 Billion CNY 98.781%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 97.081%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 95.903%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY 71.707%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY -9447.166%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 94.804%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY -95.974%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 96.656%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 94.56%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 95.899%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 88.204%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 99.38%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 94.4%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 88.891%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 90.125%
Guobang Pharma Ltd. 1.04 Billion CNY 96.692%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY -966.596%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 93.582%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 96.857%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 89.482%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY 69.189%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 93.911%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 159.555%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY 86.248%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 98.259%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY 82.37%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 96.471%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY 83.071%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 87.119%
CanSino Biologics Inc. -1.64 Billion CNY 102.092%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 86.744%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 95.357%